Tif1γ regulates the TGF-β1 receptor and promotes physiological aging of hematopoietic stem cells

The hematopoietic system declines with age. Myeloid-biased differentiation and increased incidence of myeloid malignancies feature aging of hematopoietic stem cells (HSCs), but the mechanisms involved remain uncertain. Here, we report that 4-mo-old mice deleted for transcription intermediary factor...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 111; no. 29; pp. 10592 - 10597
Main Authors Quéré, Ronan, Saint-Paul, Laetitia, Carmignac, Virginie, Martin, Romain Z., Chrétien, Marie-Lorraine, Largeot, Anne, Hammann, Arlette, de Barros, Jean-Paul Pais, Bastie, Jean-Noël, Delva, Laurent
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 22.07.2014
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The hematopoietic system declines with age. Myeloid-biased differentiation and increased incidence of myeloid malignancies feature aging of hematopoietic stem cells (HSCs), but the mechanisms involved remain uncertain. Here, we report that 4-mo-old mice deleted for transcription intermediary factor 1γ (Tif1γ) in HSCs developed an accelerated aging phenotype. To reinforce this result, we also show that Tif1γ is down-regulated in HSCs during aging in 20-mo-old wild-type mice. We established that Tif1γ controls TGF-β1 receptor (Tgfbr1) turnover. Compared with young HSCs, Tif1γ ⁻/⁻ and old HSCs are more sensitive to TGF-β signaling. Importantly, we identified two populations of HSCs specifically discriminated by Tgfbr1 expression level and provided evidence of the capture of myeloid-biased (Tgfbr1 ʰⁱ) and myeloid-lymphoid-balanced (Tgfbr1 ˡᵒ) HSCs. In conclusion, our data provide a new paradigm for Tif1γ in regulating the balance between lymphoid- and myeloid-derived HSCs through TGF-β signaling, leading to HSC aging.
Bibliography:http://dx.doi.org/10.1073/pnas.1405546111
Edited by Zhu Chen, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China, and approved June 10, 2014 (received for review March 25, 2014)
Author contributions: R.Q., J.-N.B., and L.D. designed research; R.Q., L.S.-P., V.C., R.Z.M., M.-L.C., A.L., A.H., and J.-P.P.d.B. performed research; R.Q., L.S.-P., V.C., J.-N.B., and L.D. analyzed data; and R.Q., V.C., and L.D. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1405546111